ESR2 and breast carcinoma: ERβ decreases the expression of the proangiogenic factors vascular endothelial growth factor (VEGF) and platelet-derived growth factor β (PDGFβ) in T47D breast cancer cells and reduces the number of intertumoral blood vessels.